These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 26034776)
1. Ceftaroline desensitization procedure in a pregnant patient with multiple drug allergies. Kuhlen JL; Blumenthal KG; Sokol CL; Balekian DS; Weil AA; Varughese CA; Shenoy ES; Banerji A Open Forum Infect Dis; 2015 Jan; 2(1):ofv027. PubMed ID: 26034776 [TBL] [Abstract][Full Text] [Related]
2. Desensitization to ceftaroline in a patient with multiple medication hypersensitivity reactions. Jones JM; Richter LM; Alonto A; Leedahl DD Am J Health Syst Pharm; 2015 Feb; 72(3):198-202. PubMed ID: 25596602 [TBL] [Abstract][Full Text] [Related]
3. Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults. Welte T; Kantecki M; Stone GG; Hammond J Int J Antimicrob Agents; 2019 Oct; 54(4):410-422. PubMed ID: 31404620 [TBL] [Abstract][Full Text] [Related]
4. Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens. Steed ME; Rybak MJ Pharmacotherapy; 2010 Apr; 30(4):375-89. PubMed ID: 20334458 [TBL] [Abstract][Full Text] [Related]
5. Evaluation and Management of Penicillin Allergy: A Review. Shenoy ES; Macy E; Rowe T; Blumenthal KG JAMA; 2019 Jan; 321(2):188-199. PubMed ID: 30644987 [TBL] [Abstract][Full Text] [Related]
6. Antibiotic desensitization in adults with cystic fibrosis. Burrows JA; Toon M; Bell SC Respirology; 2003 Sep; 8(3):359-64. PubMed ID: 12911831 [TBL] [Abstract][Full Text] [Related]
7. Evaluating the antibacterial activity of ceftaroline against clinical isolates of methicillin-susceptible and- resistant Staphylococcus aureus in Kuwait hospitals. Alfouzan W; Boswihi SS; Dhar R; Udo E J Infect Public Health; 2020 Oct; 13(10):1589-1591. PubMed ID: 32859552 [TBL] [Abstract][Full Text] [Related]
8. Rate and Incidence of Adverse Reactions Associated With Ceftaroline Exposure: Importance of Cutaneous Manifestations. Jansen JW; Moenster RP Ann Pharmacother; 2018 Mar; 52(3):235-239. PubMed ID: 28980484 [TBL] [Abstract][Full Text] [Related]
10. Ceftaroline for the treatment of methicillin-resistant White BP; Barber KE; Stover KR Am J Health Syst Pharm; 2017 Feb; 74(4):201-208. PubMed ID: 28179245 [TBL] [Abstract][Full Text] [Related]
11. Adverse Drug Reactions Associated with Ceftaroline Use: A 2-Center Retrospective Cohort. Blumenthal KG; Kuhlen JL; Weil AA; Varughese CA; Kubiak DW; Banerji A; Shenoy ES J Allergy Clin Immunol Pract; 2016; 4(4):740-6. PubMed ID: 27130709 [TBL] [Abstract][Full Text] [Related]
12. Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients. Pasquale TR; Tan MJ; Trienski TL; File TM J Chemother; 2015 Feb; 27(1):29-34. PubMed ID: 24621164 [TBL] [Abstract][Full Text] [Related]
13. Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. Lodise TP; Low DE Drugs; 2012 Jul; 72(11):1473-93. PubMed ID: 22779432 [TBL] [Abstract][Full Text] [Related]
14. Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Pulmonary Exacerbation in a Pediatric Cystic Fibrosis Patient. Molloy L; Snyder AH; Srivastava R; Rybak MJ; McGrath E J Pediatr Pharmacol Ther; 2014 Apr; 19(2):135-40. PubMed ID: 25024675 [TBL] [Abstract][Full Text] [Related]
15. Ceftaroline for Severe Methicillin-Resistant Cosimi RA; Beik N; Kubiak DW; Johnson JA Open Forum Infect Dis; 2017; 4(2):ofx084. PubMed ID: 28702467 [TBL] [Abstract][Full Text] [Related]
16. Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus. Sharma AD; Gutheil WG Microbiol Spectr; 2023 Feb; 11(1):e0372622. PubMed ID: 36519895 [TBL] [Abstract][Full Text] [Related]
17. Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure. Cannavino CR; Mendes RE; Sader HS; Farrell DJ; Critchley IA; Biek D; Le J; Skochko SM; Jones RN; Bradley JS Pediatr Infect Dis J; 2016 Jul; 35(7):813-5. PubMed ID: 27093165 [TBL] [Abstract][Full Text] [Related]
18. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012). Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010). Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953 [TBL] [Abstract][Full Text] [Related]
20. Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity. Rose WE; Schulz LT; Andes D; Striker R; Berti AD; Hutson PR; Shukla SK Antimicrob Agents Chemother; 2012 Oct; 56(10):5296-302. PubMed ID: 22869564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]